top of page
All Posts


Biotech Stock Catalyst Watchlist - April 2023
We've reached the end of Q1. April has a lot of events happening including 8 PDUFA's, the AACR cancer meeting, and some other company...
Apr 2, 20231 min read


Biopharma Pulse - 3/27 - 3/31 Weekly Review
Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...
Mar 31, 20231 min read
Clinical Trial Readout Diligence
Doing diligence on clinical trial readouts with our BPIQ team Reminds me of some important considerations for the likelihood of success: ⇨Prior data for the on-test drug ⇨⇨Same endpoints? ⇨⇨Not available? Then prior trial data for other drugs with the same MOA ⇨Trial design ⇨⇨ Are the characteristics of patients allowed into the trial the same? ⇨⇨⇨ Especially the severity of the disease ⇨⇨How many patients? ⇨⇨How many clinical sites? & Likelihood of stock move ⇨Market reactio
Mar 31, 20231 min read


AACR Starts April 14th!
Last updated 4/10/23 Summary: AACR is only a few weeks away - the conferences starts April 14th, also when abstract text is released What...
Mar 29, 20232 min read


AMGN v. Sanofi Ab Patent Case - What Biotech Investors Should Know
Amgen v. Sanofi Sup Ct. oral arguments took place yesterday in the ongoing PCSK9* antibody (Ab) patent case. See the attached transcript...
Mar 28, 20232 min read
AMGN v. Sanofi Ab Patent Case - What Biotech Investors Should Know
Amgen v. Sanofi Sup Ct. oral arguments took place yesterday in the ongoing PCSK9* antibody (Ab) patent case. See the attached transcript and FIG. 1. Who won the oral arguments? Verdict? Although it's hard to predict the outcome of the case from the oral arguments, I give the advantage in the orals to Sanofi Some of the Sup Ct justices don't like that AMGN's patent covers millions of antibodies (Abs) and only discloses 26 Abs And the fact that there is no structure, only funct
Mar 28, 20233 min read


Biotech Q1 '23 Final Catalyst Countdown
We've reached the final week of Q1. Anything that hasn't read out yet is coming this week! There's over 20 events still set to happen....
Mar 24, 20231 min read


Biopharma Pulse - 3/20 - 3/24 Weekly Review
Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...
Mar 24, 20231 min read


ETNB Phase 2b Data Reported!!
Summary: Phase 2b ETNB ENLIVEN data was reported today (3/22/23) & trial met primary endpoints How does this data compare to previous...
Mar 22, 20232 min read


3 Mental Health Readouts Left as March Movers!
Summary: ITCI, NRXP & VTGN are left in our March Movers list, all are in the mental health category NRXP & VTGN are March Big Movers and...
Mar 21, 20232 min read
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page
